Prothena (PRTA) Stock Chart & Stock Price History $13.18 -0.09 (-0.68%) Closing price 04:00 PM EasternExtended Trading$13.18 0.00 (0.00%) As of 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Prothena Stock Price Performance 5 Day Performance+1.69%1 Month Performance+5.23%3 Month Performance-22.49%6 Month Performance-45.01%Year-To-Date Performance-4.19%1 Year Performance-59.93% Receive PRTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prothena and its competitors with MarketBeat's FREE daily newsletter. Email Address PRTA Stock Chart for Thursday, January, 16, 2025 PRTA Chart by TradingView Prothena Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/15/2025$12.67$13.27+4.74%$13.64$12.89332,789 shs$714.05 million01/14/2025$13.13$12.67-3.50%$13.41$12.41616,804 shs$681.76 million01/13/2025$13.05$13.13+0.61%$13.30$12.39390,259 shs$706.51 million01/10/2025$14.16$13.05-7.84%$13.91$12.84521,545 shs$702.21 million01/09/2025$14.16$14.16$14.25$13.58308,898 shs$761.94 million01/08/2025$14.15$14.16+0.07%$14.25$13.58308,898 shs$761.94 million Get the Latest News and Ratings for PRTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prothena and its competitors with MarketBeat's FREE daily newsletter. 01/07/2025$13.15$14.15+7.60%$14.47$12.97535,577 shs$761.40 million01/06/2025$13.87$13.15-5.19%$14.18$13.05655,841 shs$707.59 million01/03/2025$13.67$13.87+1.46%$14.05$13.65321,824 shs$746.33 million01/02/2025$13.85$13.67-1.30%$14.50$13.53529,998 shs$735.57 million01/01/2025$13.85$13.85$15.30$12.791.42 million shs$745.26 million12/31/2024$14.88$13.85-6.92%$15.30$12.791.42 million shs$745.26 million12/30/2024$15.14$14.88-1.72%$15.25$14.64415,453 shs$800.68 million12/27/2024$15.74$15.14-3.81%$15.80$14.80475,150 shs$814.67 million12/26/2024$15.40$15.74+2.21%$15.79$14.85336,786 shs$828.66 million12/25/2024$15.40$15.40$15.43$14.95246,140 shs$828.66 million12/24/2024$15.33$15.40+0.46%$15.43$14.95246,140 shs$828.66 million12/23/2024$15.22$15.33+0.72%$15.50$14.89567,893 shs$824.89 million12/20/2024$16.01$15.22-4.93%$16.42$15.101.56 million shs$818.97 million12/19/2024$11.95$16.01+33.97%$17.66$12.203.28 million shs$861.48 million12/18/2024$14.04$11.95-14.89%$14.22$11.70856,864 shs$643.02 million12/17/2024$12.61$14.04+11.34%$14.28$12.311.05 million shs$755.48 million12/16/2024$12.79$12.61-1.41%$13.13$12.44603,029 shs$678.53 million Related Companies Denali Therapeutics Stock Chart SpringWorks Therapeutics Stock Chart Merus Stock Chart Zai Lab Stock Chart Bausch Health Companies Stock Chart Catalyst Pharmaceuticals Stock Chart Recursion Pharmaceuticals Stock Chart Gemini Therapeutics Stock Chart Twist Bioscience Stock Chart HUTCHMED Stock Chart Receive PRTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prothena and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRTA) was last updated on 1/16/2025 by MarketBeat.com Staff From Our Partnersliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prothena Co. plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Prothena With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.